Trial site
CHU Ambroise Paré
- 9running trials
- 8closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer3 trials
- Endometrial cancer3 trials
- Lung cancer3 trials
- Multiple myeloma2 trials
- Ankylosing spondylitis1 trial
- Bladder cancer1 trial
- Brain metastases1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Rheumatoid arthritis1 trial
- and 1 more
- Phase
- Phase 37 trials
- Phase 23 trials
- Phase 1/22 trials
- Status
- Completed8 trials
- Active, not recruiting4 trials
- Recruiting4 trials
- Not yet recruiting1 trial
- Lead sponsor
- Jules Bordet Institute4 trials
- Inhatarget Therapeutics2 trials
- AbbVie1 trial
- Alfasigma S.p.A.1 trial
- Bioxodes S.A.1 trial
- and 8 more
Running trials
Recruiting
Study on the Clinical Efficacy of Teclistamab and Talquetamab
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Brain metastases1 recruiting
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Multiple myeloma1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Completed
A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients
Active, not recruiting
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
Completed
Completed
Multiorgan Metabolic Imaging Response Assessment of Abemaciclib
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026